P977: THE VENOUS THROMBOEMBOLISM RISK ASSESMENT MODELS IN MULTIPLE MYELOMA

P977: THE VENOUS THROMBOEMBOLISM RISK ASSESMENT MODELS IN MULTIPLE MYELOMA

Bibliographic Details
Main Authors:	Tugcan Alp Kirkizlar, Onur Kirkizlar, Ahmet Muzaffer Demir, Elif Gulsum Umit
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000970812.20451.72

Similar Items

Economic analysis of oral posaconazole prophylaxis in acute myeloid leukemia during remission induction in Turkey
by: Elif Gulsum Umit, et al.
Published: (2020-05-01)

Comparison of Clinical Scoring Systems in the Management of Patients with Microangiopathic Hemolytic Anemia and Thrombocytopenia
by: Mehmet Baysal, et al.
Published: (2021-02-01)

Could Antinuclear Antibody Positivity Be a Factor Affecting Treatment Response in Immune Thrombocytopenia Patients on Eltrombopag?
by: Mehmet Baysal, et al.
Published: (2022-02-01)

Thalidomide for the Management of Bleeding Episodes in Patients with Hereditary Hemorrhagic Telangiectasia: Effects on Epistaxis Severity Score and Quality of Life
by: Mehmet Baysal, et al.
Published: (2019-02-01)

Sticky Platelet Syndrome in Patients with Uninduced Venous Thrombosis
by: Emre Tekgündüz, et al.
Published: (2013-03-01)

CD11b Expression in Acute Myeloid Leukemia is Associated With Hemostatic Complications and Response to Treatment
by: Mehmet BAYSAL, et al.
Published: (2020-04-01)

Pros and cons for fluorescent in situ hybridization, karyotyping and next generation sequencing for diagnosis and follow-up of multiple myeloma
by: Ikbal Atli E, et al.
Published: (2021-03-01)

Venous thromboembolism in multiple myeloma is associated with increased mortality
by: Martin W. Schoen, et al.
Published: (2020-10-01)

P977: BISPECIFIC CS1-BCMA CAR-T CELLS ARE CLINICALLY ACTIVE IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA
by: C. Li, et al.
Published: (2022-06-01)

Genetic Diagnosis of Hereditary Hemorrhagic Telangiectasia: Four Novel Pathogenic Variations in Turkish Patients
by: Mehmet Baysal, et al.
Published: (2020-01-01)

Validation of Risk-Adapted Venous Thromboembolism Prediction in Multiple Myeloma Patients
by: Aisling Barrett, et al.
Published: (2021-08-01)

Nursing management of treatment-related venous thromboembolism in patients with multiple myeloma
by: Bianhong Yang, et al.
Published: (2023-04-01)

Evaluation of the Khorana score for prediction of venous thromboembolism in patients with multiple myeloma
by: Kristen M. Sanfilippo, et al.
Published: (2022-01-01)

Multiple Liver and Muscle Abscesses and Sepsis with Bacillus pantothenticus in a Leukemia Patient
by: Elif Gülsüm Ümıt, et al.
Published: (2014-08-01)

IGA MULTIPLE MYELOMA ASSESMENT WITH HEVYLITE ASSAY
by: G Virginia, et al.
Published: (2023-10-01)

Hematologists’ awareness of venous thromboembolism in multiple myeloma: a national survey in China
by: Qun Li, et al.
Published: (2023-12-01)

Quality Improvement at an Academic Cancer Center: Venous Thromboembolism Prophylaxis in Patients With Multiple Myeloma
by: Rachid Baz MD, et al.
Published: (2020-06-01)

Hypogammaglobulinemia and Poor Performance Status are Predisposing Factors for Vancomycin-Resistant Enterococcus Colonization in Patients with Hematological Malignancies
by: Elif Gülsüm Ümit, et al.
Published: (2017-03-01)

P969: COMPARISON OF VENOUS THROMBOEMBOLISM INCIDENCE IN MULTIPLE MYELOMA PATIENTS RECEIVING LENALIDOMIDE-BASED REGIMENS WITH RIVAROXABAN OR ASPIRIN THROMBOPROPHYLAXIS
by: Y. Wang, et al.
Published: (2022-06-01)

The Relationship Between Factor VIII and Coronary Artery Diseases
by: Cenk Emre Meral, et al.
Published: (2012-12-01)

Incidence of Venous Thromboembolism in Multiple Myeloma Patients across Different Regimens: Role of Procoagulant Microparticles and Cytokine Release
by: Antonio Gidaro, et al.
Published: (2022-05-01)

Risk of Venous Thromboembolism in Multiple Myeloma Patients During the Immediate Peri-Autologous Hematopoietic Cell Transplantation Phase
by: Hussein Awada MD, et al.
Published: (2023-06-01)

Asian venous thromboembolism guidelines: updated recommendations for the prevention of venous thromboembolism
by: Liew, Ngoh Chin, et al.
Published: (2017)

ON THE DATE OF THE OLBIAN CALENDAR GRAFFITO SEG 30: 977
by: Sofia Andreeva
Published: (2022-01-01)

Venous anomalies and thromboembolism
by: Caroline Dix, et al.
Published: (2023-04-01)

Osteoporosis and venous thromboembolism
by: Irina Aleksandrovna Baranova, et al.
Published: (2011-02-01)

Approach to: Venous Thromboembolism
by: Salima Ramdani
Published: (2022-10-01)

Preeclampsia and venous thromboembolism
by: K. N. Grigoreva, et al.
Published: (2022-07-01)

Venous thromboembolic complications
by: G. G. Khubulava, et al.
Published: (2019-02-01)

Quadragésimo ano do parecer CFE nº 977/65
by: Carlos Roberto Jamil Cury
Published: (2005-01-01)

Drug Induced Thrombotic Microangiopathy with Certolizumab Pegol
by: Mehmet Baysal, et al.
Published: (2018-09-01)

Risk Factors and Risk Stratification of Thromboembolic Risk in Patients with Multiple Myeloma
by: Roza Chaireti, et al.
Published: (2022-08-01)

Introduction to venous thromboembolism and prophylaxis
by: Howard, A, et al.
Published: (2006)

Prevention and treatment of venous thromboembolism
by: Casadei, B, et al.
Published: (2020)

Poststroke venous thromboembolism in Asia
by: Tan, K.S., et al.
Published: (2010)

Pediatric Orthopaedic Venous Thromboembolism
by: Neha Mulpuri, MD, et al.
Published: (2024-03-01)

Air travel and venous thromboembolism
by: Mendis Shanthi, et al.
Published: (2002-01-01)

Hematocrit and incidence of venous thromboembolism
by: Aaron R. Folsom, et al.
Published: (2020-03-01)

Editorial: Venous thromboembolism and pregnancy
by: Bernard Tardy, et al.
Published: (2022-12-01)

Clinical overview of venous thromboembolism
by: Gustav Schellack, et al.
Published: (2016-01-01)